Bellicum Pharmaceuticals, Inc.


Updates from The Motley Fool

Latest updates on Bellicum Pharmaceuticals from Fool.com.
My Top Biotech Stock for 2016

Bellicum Pharmaceuticals is a clinical-stage biotech that could have a banner year in 2016. Here'...



Stock Performance

View Interactive BLCM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bellicum Pharmaceuticals.
Current Price: $14.37
Prev Close: $13.91
Open: $13.99
Bid: $13.61
Ask: $13.75
Day's Range: $13.82 - $14.50
52wk Range: $7.51 - $23.11
Volume: 407,308
Avg Vol 531,257
Market Cap: $390M
P/E (ttm): -5.41
EPS (ttm): ($2.57)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Bellicum Pharmaceuticals.
CAPS Rating 5 out of 5
 
68 Outperform
0 Underperform
CAPS All Stars
 
21 Outperform
0 Underperform

How do you think Bellicum Pharmaceuticals will perform against the market?



You pick for Bellicum Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Bellicum Pharmaceuticals.

Bellicum Pharmaceuticals, Inc.

  • Exchange: NASDAQ